ABSTRACT. Objective. To assess neutrophil CD11b and circulating interleukin 8 (IL-8) as markers of earlyonset infection in neonates.Methods. The study comprised 39 neonates, with a gestational age of 29 to 41 weeks, suspected of infection within 48 hours of life. Neutrophil surface expression of CD11b was quantified with flow cytometry and plasma IL-8 with an enzyme-linked immunosorbent assay. Both data were available from 35 of 39 neonates. Serum C-reactive protein was determined at initial evaluation and, later, on the basis of the clinical picture. Neonates were allocated retrospectively into 2 groups. In the sepsis group (N ؍ 22), 4 had culture-proven sepsis, and 14 had an antenatal risk factor for infection. In the possibleinfection group (N ؍ 13), each neonate had a noninfective disorder, but co-occurring infection remained a possibility. Twelve healthy term infants served as controls.Results. CD11b expression and IL-8 levels both increased in order of sepsis > possible infection > healthy. Sensitivity and specificity by the CD11b test for sepsis were equal, at 1.00, and those by the IL-8 test 0.91 and 1.00, respectively; 6 (17.1%) of the 35 neonates had CD11b and IL-8 below cutoff levels.Conclusions. Measuring neutrophil CD11b expression and circulating IL-8 provides a means to identify early-onset neonatal sepsis. The findings may be helpful in planning strategies to safely reduce the use of antimicrobials in neonates. Pediatrics 2001;108(1). URL: http:// www.pediatrics.org/cgi/content/full/108/1/e12; circulating IL-8, C-reactive protein, early-onset sepsis, neutrophil CD11b expression, newborn infant.ABBREVIATIONS. IL, interleukin; CRP, C-reactive protein; RFU, relative fluorescence unit; CI, confidence interval; ROC, receiveroperating characteristic curve. N eonatal sepsis is a life-threatening disease with an incidence of 1 to 10 per 1000 livebirths, and a mortality rate of 15% to 50%. 1 The clinical signs are nonspecific and indistinguishable from those caused by a variety of neonatal noninfective disorders, such as aspiration syndrome, maladaptation, and respiratory distress syndrome. It is therefore recommended for all neonates who develop these signs to start empirical antimicrobial therapy. 2,3 This clinical practice, however, renders many neonates unduly susceptible to side effects of antimicrobial agents, increases hospital costs, and promotes the development and spread in hospitals of resistant bacterial strains. 4 Therefore, markers are needed that reliably identify truly infected neonates.Invading microbes activate the host's innate immune cells, 5 including neutrophils and monocytes. Activated phagocytes produce inflammatory cytokines such as tumor necrosis factor-␣, interleukin (IL)-1, and IL-8. The release of these mediators into the circulation results in the development of systemic inflammation in adults 6 and children. 7 Systemic inflammation is considered to play an important role in the development of organ failure, 8 the major cause of mortality in sepsis. Elevated blood levels...